This June, Canadians celebrate Men’s Health Month in recognition of the unique health needs and conditions that affect people of the male sex locally and around the world. Vancouver Coastal Health Research Institute researcher Dr. Wellam Yu Ko is at the forefront of trailblazing research and insights into how men can steer the clearest path to health and long-term vitality.
At the age of 16, John Chernesky lost the use of his legs following a car crash that damaged his cervical spine. Now in his mid-40s, the tetraplegic with moderate to good hand function has made it part of his life’s mission to help find new treatments for spinal cord injury (SCI) as an active participant in research and the consumer engagement program manager with Praxis Spinal Cord Institute.
The YWCA Women of Distinction Awards is a nationally recognized event that celebrates extraordinary women leaders and businesses in Metro Vancouver. Congratulations to the VCHRI award recipients for their groundbreaking work in health care sustainability, substance use education and environmental infection control.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Tolerability, Safety, and Efficacy of PRAX-944 in the Treatment of Adults with Essential Tremor
Taking innovative research from concept to application is critical for improving health care systems and the well-being of patients. VCHRI is proud to support investigators and their groundbreaking health research with the Innovation and Translational Research Awards. This year’s recipients are putting new knowledge into practice, implementing research outcomes and turning discoveries into commercial opportunities.
The 2022 Innovation and Translational Research Award recipients are:
What arguably began with the Fitbit has evolved into a technological space where runners can choose from a variety of wearables to monitor training progress with every stride.
It is here — at the intersection of ease of use and reliability — that Dr. Chris Napier, a sports physiotherapist and principal investigator at the Vancouver Coastal Health Research Institute (VCHRI), is studying wearable technology.
Researchers from the University of British Columbia (UBC) and Vancouver Coastal Health (VCH) have received $1 million from Canada’s Stem Cell Network to conduct research and a clinical trial for one of the world’s first genetically engineered cell replacement therapies for type 1 diabetes.
The researchers say the study is an important step toward developing a potential functional cure for type 1 diabetes.
